Johns Hopkins Medicine: Circulating Tumor DNA Levels Predict Treatment Outcomes for Patients With Gastroesophageal Cancer Treated With a Novel Immunotherapy Combination
March 20, 2024
March 20, 2024
BALTIMORE, Maryland, March 20 (TNSres) -- Johns Hopkins Medicine issued the following news release:
Monitoring levels of DNA shed by tumors and circulating in the bloodstream could help doctors accurately assess how gastroesophageal cancers are responding to treatment, and potentially predict future prognosis, suggests a new study led by researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.
The study tracked m . . .
Monitoring levels of DNA shed by tumors and circulating in the bloodstream could help doctors accurately assess how gastroesophageal cancers are responding to treatment, and potentially predict future prognosis, suggests a new study led by researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.
The study tracked m . . .